Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Planned for Nov 12, 2026 · Notice filed Nov 12, 2026
An Aquestive Therapeutics officer told the SEC about a plan to sell $26K of Aquestive Therapeutics shares around Nov 12, 2026. The filing says the shares were acquired as compensation.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider filing
Traded Nov 10 · filed 2 days later
Routine share withholding; mechanical by default.
Insider buying
First insider buy since Jun 2022Traded Nov 10 · filed 2 days later
An Aquestive Therapeutics director paid $4.2K out of pocket for Aquestive Therapeutics shares.
Insider buying
First insider buy since Jun 2022Traded Nov 10 · filed 2 days later
An Aquestive Therapeutics director paid $95K out of pocket for Aquestive Therapeutics shares. Shares held went up 2235% with this purchase.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
